Literature DB >> 4958088

Interaction of the genes of ocular retardation and microphthalmia in mice.

B V Konyukhov, M V Sazhina.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 4958088

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN： 0015-5500            Impact factor:   0.906


× No keyword cloud information.
  7 in total

Review 1.  The other pigment cell: specification and development of the pigmented epithelium of the vertebrate eye.

Authors:  Kapil Bharti; Minh-Thanh T Nguyen; Susan Skuntz; Stefano Bertuzzi; Heinz Arnheiter
Journal:  Pigment Cell Res       Date:  2006-10

2.  Genetic control over the duration of G 1 phase.

Authors:  B V Konyukhov; M V Sazhina
Journal:  Experientia       Date:  1971-08

3.  Mapping of genetic modifiers affecting the eye phenotype of ocular retardation (Chx10or-J) mice.

Authors:  Gilbert Wong; Sharmila Basu Conger; Margit Burmeister
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

4.  Absence of chx10 causes neural progenitors to persist in the adult retina.

Authors:  Nathalie S Dhomen; Kam S Balaggan; Rachael A Pearson; James W Bainbridge; Edward M Levine; Robin R Ali; Jane C Sowden
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

5.  Vsx2 controls eye organogenesis and retinal progenitor identity via homeodomain and non-homeodomain residues required for high affinity DNA binding.

Authors:  Changjiang Zou; Edward M Levine
Journal:  PLoS Genet       Date:  2012-09-20       Impact factor: 5.917

6.  Genetic chimeras reveal the autonomy requirements for Vsx2 in embryonic retinal progenitor cells.

Authors:  Crystal L Sigulinsky; Massiell L German; Amanda M Leung; Anna M Clark; Sanghee Yun; Edward M Levine
Journal:  Neural Dev       Date:  2015-04-27       Impact factor: 3.842

7.  Alternative promoter use in eye development: the complex role and regulation of the transcription factor MITF.

Authors:  Kapil Bharti; Wenfang Liu; Tamas Csermely; Stefano Bertuzzi; Heinz Arnheiter
Journal:  Development       Date:  2008-02-13       Impact factor: 6.868
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.